News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
407
Sources here
22
Companies here
13
Search results Stored financial headlines

Active search

407 matching headlines

Ticker or company: DIAMMain company stories
Clear
Latest

MarketBeat Earnings

TFR Capital LLC. Makes New $1.46 Million Investment in Diamondback Energy, Inc. $FANG

TFR Capital LLC initiated a new position in Diamondback Energy, Inc. (FANG) during the second quarter, purchasing 8,287 shares valued at approximately $1.46 million. This investment comes as institutional investors collectively own 90.01% of the company. Diamondback Energy recently reported strong quarterly earnings, beating estimates with an EPS of $6.48 and a 51.2% year-over-year revenue increase to $5.56 …

Oppenheimer Asset Management Inc. Makes New Investment in Diamondback Energy, Inc. $FANG

Oppenheimer Asset Management Inc. has initiated a new position in Diamondback Energy, Inc. (NASDAQ:FANG), purchasing 36,505 shares valued at approximately $6.417 million during the second quarter. This new investment comes as other institutional investors, such as Boston Partners and Geode Capital Management LLC, also …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Diamondback Energy (FANG) Is Up 7.7% After Earnings Beat, Guidance Hike And Dividend Boost

Diamondback Energy (FANG) saw its stock rise 7.7% after reporting strong Q2 2026 results, including higher production, revenue, and net income, along with declaring a $1.10 per-share dividend. The company also increased its full-year 2026 production guidance and continued its share repurchase program, reinforcing …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Dockside LLC Makes New $2.12 Million Investment in Diamondback Energy, Inc. $FANG

Dockside LLC recently acquired a new stake of 12,038 shares, valued at $2.12 million, in Diamondback Energy, Inc. during the second quarter. This investment is part of broader institutional interest, with such investors collectively owning 90.01% of the company. Diamondback Energy reported strong financials, …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy Inc. stock outperforms competitors on strong trading day

Shares of Diamondback Energy Inc. (FANG) increased by 1.48% to $202.47 on Friday, despite a generally poor trading session for the broader stock market. The S&P 500 Index and Dow Jones Industrial Average both saw declines, yet Diamondback Energy's stock managed to rise, breaking …

FANG main company FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays Adjusts Diamondback Energy PT to $221 From $232, Maintains Overweight Rating

Barclays has adjusted its price target for Diamondback Energy (NASDAQ: FANG) to $221, down from its previous target of $232. Despite this reduction, the firm has decided to maintain its Overweight rating on the energy company's stock. This indicates a continued positive outlook on …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DiaMedica Therapeutics Inc. (DMAC) stock price, news, quote and history

This article provides a comprehensive overview of DiaMedica Therapeutics Inc. (DMAC), including its current stock price, financial statistics, historical data, and analyst insights. It highlights DMAC as a clinical-stage biopharmaceutical company focused on ischemic diseases, with its lead candidate DM199 in Phase 2/3 trials. …

DMAC main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 59.9% DMAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy Leads Five Dividend Payouts on August 13

Diamondback Energy is leading five companies in dividend payouts on August 13, distributing $309 million to shareholders at $1.10 per share. Three of the top five companies making significant dividend payments are in the oil and gas sector, including Viper Energy and Expand Energy, …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can FANG's Higher 2026 Output Guidance Keep Earnings Momentum Alive?

Diamondback Energy (FANG) has raised its 2026 production outlook while keeping its full-year capital budget unchanged, indicating a focus on capital efficiency. The company's Q2 earnings beat expectations due to production growth and improved oil prices, supported by efficiency gains in drilling. However, risks …

FANG main company FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy, Inc. (FANG) Stock forecasts

Argus has increased its rating for Diamondback Energy (FANG) to a BUY. The company is an independent oil and gas producer focused exclusively on the Permian Basin in the United States, with a current price of $198.43.

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy Stock Outlook: Is Wall Street Bullish or Bearish?

Diamondback Energy (FANG) has significantly outperformed the S&P 500 over the past year, with its shares climbing 45%. The company recently reported strong Q2 FY2026 earnings, beating estimates with a 51.2% year-over-year revenue increase and raising full-year guidance. Despite a slight bearish shift in …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Everyone Is Watching DiamondRock Hospitality (DRH) Right Now

DiamondRock Hospitality (DRH) is attracting investor attention due to strong Q2 2026 earnings, increased dividends, an active capital return program, and interest in acquisitions. The company's stock has seen significant gains, up 34.1% year-to-date and 57.9% over the past year. Despite being considered 8.2% …

DRH main company
Sharemaestro market context Trend signal active 52 weeks +51.0% DRH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy Chief Executive Officer Sold Shares Worth Over $1M

Diamondback Energy's Chief Executive Officer, Van'T Hof Matthew Kaes, sold 5,000 shares of common stock for a total of $1,012,316. The shares were sold on August 11, 2026, at a weighted average price of $202.4632 per share, with individual transaction prices ranging from $202.325 …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DiaMedica Therapeutics (DMAC) CEO receives 60,200 RSU award vesting over four years

DiaMedica Therapeutics Inc.'s President & CEO, Dietrich John Pauls, was granted 60,200 restricted stock units (RSUs). These RSUs will vest in four equal annual installments, contingent on his continued service. Following this award, Pauls beneficially holds 128,791 voting common shares, including deferred share units.

DMAC main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 59.9% DMAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamondback Energy (FANG) CEO sells 5,000 shares around $202, retains 125,940

Diamondback Energy (FANG) CEO Matthew Kaes Van't Hof sold 5,000 shares of common stock on August 11, 2026, at a weighted average price of $202.4632 per share, totaling approximately $1.01 million. Following this transaction, Van't Hof directly retains 125,940 shares of the company's common …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Black Diamond Settles HMI Cancer-Drug Discovery Patent Lawsuit

Black Diamond Therapeutics Inc. has settled a patent infringement lawsuit filed by HMI Medical Innovations LLC. HMI had alleged that Black Diamond's cancer therapy development infringed on six of its patents. The companies reached a confidential settlement and license agreement, leading to the dismissal …

BDTX main company
Sharemaestro market context Price below Trend Line 52 weeks -30.8% · Next-week setup negative 44.8% BDTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here's How Much $100 Invested In Diamondback Energy 5 Years Ago Would Be Worth Today

Diamondback Energy (NASDAQ: FANG) has significantly outperformed the market over the last five years, with an average annual return of 22.7%. An investment of $100 in FANG stock five years ago would now be worth $266.67, highlighting the power of compounded returns. The company …

FANG main company
Sharemaestro market context Trend signal active 52 weeks +43.9% FANG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DiaMedica Therapeutics reports Q2 net loss $10.1M, cash $43.5M; advances DM199 clinical programs

DiaMedica Therapeutics reported a Q2 2026 net loss of $10.1 million and ended the quarter with $43.5 million in cash, projecting a cash runway through 2027. The company is advancing its DM199 clinical programs, including positive Phase 2 results for late-onset preeclampsia, ongoing enrollment …

DMAC main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 59.9% DMAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

DiaMedica Therapeutics reported its Q2 2026 financial results and provided business updates, highlighting progress in its clinical trials for preeclampsia, fetal growth restriction (FGR), and acute ischemic stroke (AIS). The company announced the completion of enrollment for the first cohort of its Phase 2 …

DMAC main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 59.9% DMAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context